Center for Medicine in the Public Interest
The Center for Medicine in the Public Interest (CMPI) is a non-profit medical issues research group. It was founded by the Pacific Research Institute. CMPI's research agenda deals with clinical outcomes and econometric studies that analyze the value of new medicines and genomic and molecular-based medical innovation.
CMPI is a 501(c)3 organization and as such is not permitted to devote a substantial part of its activity to lobbying. Its officers have written articles on various issues including price controls on pharmaceutical products in publicly funded healthcare schemes in the United States, and restrictions on advertising in the European Union. The Economist Intelligence Unit has written that the organisation generally takes a pro-drug industry viewpoint.
CMPI Senior Fellows include:
- Marc Siegel
- Doug Badger
- John F. P. Bridges
- Jacob Arfwedson
CMPI has published studies on the value of new cancer drugs, the cost-effectiveness of certain Alzheimer's treatments, evidence-based medicine, drug counterfeiting and healthcare terrorism.
- Herper, Matthew (2007-07-25). "The Nissen Doctrine". Forbes. Retrieved 2008-01-14.
- Lee Fang (Nov 18, 2009). "Exclusive: Attacks On Health Reform Orchestrated By Yet Another Shadowy Corporate Front Group — ‘CMPI’". Center for American Progress. Retrieved 19 November 2009.
- Goldberg, Robert (2006-12-25). "HillaryCare Comes Back". The Weekly Standard (News America Incorporated). Retrieved 2008-01-14.
- Pitts, Peter J. (2006-04-12). "Power to the Patients". Wall Street Journal. Retrieved 2008-01-14.
- "USA healthcare: FDA centenary prompts politicking". Economist Intelligence Unit (Economist Group). 2006-07-05. Retrieved 2008-01-14.
- Jason Lee Miller (2008-08-01). "Are Google Results Hazardous To Your Health?". WebProNews. iEntry, Inc. Retrieved 2008-01-14.
- Laurie Sullivan (2006-06-13). "Pharmaceuticals Slowly Adopting RFID To Protect Prescription Drug Supplies". Information Week. CMP Media LLC. Retrieved 2008-01-14.